Physician profile

Jonathan D Owens

Orthopaedic Surgery · Massapequa, NY

NPI 1801896337

$3,280.89

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$204.60

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $2,781.85 2019-2022
Depuy Synthes Sales INC. $242.60 2022-2023 Va-Lcp
Stryker Corporation $86.76 2023 Mako
Heraeus Medical, LLC. $51.31 2019
Orthosensor INC. $43.14 2020
Bioventus LLC $21.95 2019
Horizon Therapeutics Plc $21.89 2022
Radius Health, INC. $16.28 2020
Convatec INC. $15.11 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jonathan D Owens

$3,280.89

in general payments reported 2019-2025

Years
2019-2023
Top company
Zimmer Biomet Holdings, INC.

https://glasscript.com/doctor/172296/jonathan-d-owens

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.